We retrospectively analyzed data of 224 patients with unresectable advanced or recurrent colorectal cancer from the Fukuyama Medical Center for Patients, who were treated with concomitant cytotoxic anticancer drug and VEGF or EGFR inhibitor between April 2016 and October 2021. The gene discussed is EGFR; the disease is colorectal cancer.